Clinical and translational studies have reported substantial changes in body weight and adipose tissue mass when the compound is evaluated in controlled trials and metabolic models, suggesting that multi-receptor agonism can alter energy balance through integrated endocrine signaling mechanisms [2][3][5]
By activating GLP-1 and GIP receptors, it enhances insulin secretion (when glucose is present) and suppresses appetite, similar to existing incretin therapies [7] [8]
Hormonal shifts compound the situation
Those making the compounded, cheaper version have said the companies own their recipes, but not the ingredients and that their own versions are different enough to allow them to continue
She revealed that she turned to a GLP-1 medication after years of frustration with postpartum weight
These changes often occur due to rapid fat and in some cases, muscle loss, which can leave skin looking more loose and aged, particularly on the face and buttocks